Popular Articles
Stretch Mark Remedies

Study Confirms Effectiveness Of Innovative Prism Glasses For Hemianopia Patients
In a study of specially designed peripheral prism glasses for hemianopia patients (blinded in half the visual field in both eyes), scientists found that two-thirds of patients continued to wear the glasses at the end of the study period and beyond, indicating a high level of success. They also found that the brains of patients had not fully remapped to adjust for the prisms, which means that improved training in their use could further enhance the benefits, says principal investigator, Dr. Eli Peli, a senior scientist at Schepens Eye Research Institute and inventor of the glasses.
generic viagra online
Use Of Lenalidomide In Patients With Multiple Myeloma Having Already Received At Least Two Previous Therapies Approved By NICE, UK
A review of the NICE decision on the approval of lenalidomide is published in a special report Online First and in the July edition of The Lancet Oncology. About 2,000 multiple myeloma sufferers in the UK could benefit from the drug and improve their life expectancy pending a decision by The UK National Institute for Health and Clinical Excellence (NICE). Patients who have received two or more previous therapies could receive lenalidomide, and the cost of cycles beyond the twenty-sixth cycle of treatment would be met by the drug manufacturer.
News of the day
Prevalence Of Ureaplasma Urealyticum And Mycoplasma Hominis In Women With Chronic Urinary Symptoms
UroToday.com - Ureaplasma urealyticum and Mycoplasma Hominis are members of a unique group of microorganisms commonly identified in the genital tract of women. With the onset of sexual intercourse the prevalence of Mycoplasma increases dramatically an isolation is strongly dependent on the number of sexual partners. Convincing evidence of an infection caused by genital Mycoplasma is not easy, because they usually are not isolated in pure culture, making the evaluation even more difficult.
Health Insurance

Improvement In Diabetes Patient Care With Electronic Tracking System

A recent study published in the Canadian Medical Association Journal (CMAJ) reports that diabetes care and clinical outcomes are improved by an electronic system with personalized patient information shared by diabetes patients and their primary care providers. A total of 511 patients and 46 family physicians and nurse-practitioners were involved in the study. Web-based tools integrated with five different types of electronic health records were on hand, as well as an automated telephone reminder system and a mailing of color-coded materials to half the study sample. There was improvement for 62 percent of the patients compared to 42.6 percent in the control group. Intervention patients reported greater satisfaction with their diabetes care. About 23 million people are affected by diabetes, which represents approximately 7 percent of the populations of Canada and the US. There are $105 billion in direct annual healthcare costs. The majority of diabetes care is community-based, and is largely managed by primary care physicians. This research is one of the first randomized trials to break new ground in community-based primary care. It is the first trial of its kind in Canada. Dr. Anne Marie Holbrook of McMaster University and coauthors write: "Despite the technical challenges for both patients and physicians, we have demonstrated that the care of a complex chronic disease can be improved with electronic tracking and decision support shared by family physician and patient." In an associated comment, Dr. Richard Grant and Dr. Blackford Middleton of Harvard Medical School say the results of the study "provide strong evidence that complex research interventions can and should be implemented in community-based practices." Further development will focus on creating patient-centered rather than disease-focused systems. The aim is to address a wide range of patient concerns and help clinical management of complex diseases outside of a visit to a doctor or nurse. "Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial" Anne Holbrook, MD PharmD, Lehana Thabane, PhD, Karim Keshavjee, MD MBA, Lisa Dolovich, PharmD MSc, Bob Bernstein, PhD MDCM, David Chan, MD MSc, Sue Troyan, Gary Foster, PhD, Hertzel Gerstein, MD MSc for the COMPETE II Investigators CMAJ ò€¢ July 7, 2009; 181 (1-2). doi:10.1503/cmaj.081272 "Improving primary care for patients with complex chronic diseases: Can health information technology play a role?" Richard W. Grant and Blackford Middleton Can. Med. Assoc. J. 2009 181: 17-18. cmaj Written by Stephanie Brunner (B.A.) Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):